United States

Alexion Pharma LLC (TRMS)

Track

Track

Ticker: TRMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Williams Glen SVP, Technical Operations Officer
Transaction date
Sale
Price
113.13
Quantity 12,146 +37.1%
Value US$2,395,368
Williams Glen SVP, Technical Operations Officer
Transaction date
Sale
Price
374.73
Quantity 9,205 -25.4%
Value US$434,583
Williams Glen SVP, Technical Operations Officer
Transaction date
Planned sale
Price
298.05
Quantity 86,364 -32.2%
Value US$376,045
Williams Glen SVP, Technical Operations Officer
Transaction date
Planned sale
Price
206.97
Quantity 100 -15.0%
Value US$20,697
Williams Glen SVP, Technical Operations Officer
Transaction date
Planned sale
Price
206.27
Quantity 400 -37.5%
Value US$82,508
Williams Glen SVP, Technical Operations Officer
Transaction date
Planned sale
Price
204.94
Quantity 400 -27.2%
Value US$81,976
Williams Glen SVP, Technical Operations Officer
Transaction date
Planned sale
Price
203.99
Quantity 666 -31.2%
Value US$135,857
Quinn Anthony EVP, CMO & Head of R&D Officer
Transaction date
Planned sale
Price
110.00
Quantity 10,000 -64.0%
Value US$1,100,000
Quinn Anthony EVP, CMO & Head of R&D Officer
Transaction date
Planned sale
Price
105.00
Quantity 10,000 -39.0%
Value US$1,050,000
Williams Glen SVP, Technical Operations Officer
Transaction date
Planned sale
Price
96.08
Quantity 39,863 -98.8%
Value US$3,830,037
Williams Glen SVP, Technical Operations Officer
Transaction date
Planned sale
Price
96.04
Quantity 2,769 -85.5%
Value US$265,935
Quinn Anthony EVP, CMO & Head of R&D Officer
Transaction date
Planned sale
Price
93.76
Quantity 29,503 -65.4%
Value US$2,766,201
Heberlig Chris SVP, Finance and Business Ops. Officer
Transaction date
Planned sale
Price
105.74
Quantity 300 -43.5%
Value US$31,722
Heberlig Chris SVP, Finance and Business Ops. Officer
Transaction date
Planned sale
Price
104.57
Quantity 1,510 -68.6%
Value US$157,901
Heberlig Chris SVP, Finance and Business Ops. Officer
Transaction date
Planned sale
Price
103.55
Quantity 3,290 -59.9%
Value US$340,680
Heberlig Chris SVP, Finance and Business Ops. Officer
Transaction date
Planned sale
Price
102.46
Quantity 900 -14.1%
Value US$92,214
Heberlig Chris SVP, Finance and Business Ops. Officer
Transaction date
Planned sale
Price
101.38
Quantity 600 -8.6%
Value US$60,828
Heberlig Chris SVP, Finance and Business Ops. Officer
Transaction date
Planned sale
Price
100.44
Quantity 900 -11.4%
Value US$90,396
BOESS CARSTEN SVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
101.69
Quantity 1,842 -100.0%
Value US$187,313
BOESS CARSTEN SVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
100.74
Quantity 16,716 -90.1%
Value US$1,683,970
BOESS CARSTEN SVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
99.97
Quantity 14,750 -44.3%
Value US$1,474,558
BOESS CARSTEN SVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
98.85
Quantity 8,989 -21.3%
Value US$888,563
BAKER JULIAN Non-Executive Director Large shareholder
Transaction date
Purchase
Price
94.19
Quantity 1,000,000 +12.2%
Value US$94,190,000
BAKER FELIX Non-Executive Director Large shareholder
Transaction date
Purchase
Price
94.19
Quantity 1,000,000 +12.2%
Value US$94,190,000
Heberlig Chris Group Vice President, Finance Officer
Transaction date
Planned sale
Price
93.04
Quantity 300 -49.7%
Value US$27,912
Heberlig Chris Group Vice President, Finance Officer
Transaction date
Planned sale
Price
92.10
Quantity 1,156 -65.7%
Value US$106,468
Heberlig Chris Group Vice President, Finance Officer
Transaction date
Planned sale
Price
91.34
Quantity 2,844 -61.8%
Value US$259,771
Heberlig Chris Group Vice President, Finance Officer
Transaction date
Planned sale
Price
89.90
Quantity 1,800 -28.1%
Value US$161,820
Patel Sanj K President & CEO Executive Director
Transaction date
Planned sale
Price
90.06
Quantity 26,960 -96.3%
Value US$2,428,018
Patel Sanj K President & CEO Executive Director
Transaction date
Planned sale
Price
87.26
Quantity 4,488 -13.8%
Value US$391,623
Patel Sanj K President & CEO Executive Director
Transaction date
Planned sale
Price
87.55
Quantity 13,536 -29.4%
Value US$1,185,077
Patel Sanj K President & CEO Executive Director
Transaction date
Planned sale
Price
87.25
Quantity 5,016 -9.8%
Value US$437,646
BOESS CARSTEN SVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
80.11
Quantity 22,904 -100.0%
Value US$1,834,839
BOESS CARSTEN SVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
80.00
Quantity 1,000 -100.0%
Value US$80,000
BOESS CARSTEN SVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
80.00
Quantity 1,500 -60.0%
Value US$120,000
Goldberg Mark Alan EVP, Medical & Reg. Strategy Officer
Transaction date
Planned sale
Price
65.24
Quantity 790 -58.4%
Value US$51,540
Goldberg Mark Alan EVP, Medical & Reg. Strategy Officer
Transaction date
Planned sale
Price
65.06
Quantity 4,200 -88.2%
Value US$273,252
Goldberg Mark Alan EVP, Medical & Reg. Strategy Officer
Transaction date
Planned sale
Price
65.01
Quantity 9,379 -94.3%
Value US$609,729
Quinn Anthony EVP, CMO & Head of R&D Officer
Transaction date
Planned sale
Price
72.88
Quantity 300 -1.2%
Value US$21,864
Quinn Anthony EVP, CMO & Head of R&D Officer
Transaction date
Planned sale
Price
71.96
Quantity 700 -2.6%
Value US$50,372
Quinn Anthony EVP, CMO & Head of R&D Officer
Transaction date
Planned sale
Price
70.50
Quantity 400 -1.5%
Value US$28,200
Quinn Anthony EVP, CMO & Head of R&D Officer
Transaction date
Planned sale
Price
69.88
Quantity 8,600 -24.2%
Value US$600,968
Williams Glen SVP, Technical Operations Officer
Transaction date
Planned sale
Price
108.02
Quantity 700 -72.5%
Value US$75,614
Quart Barry D Non-Executive Director
Transaction date
Planned sale
Price
100.00
Quantity 1,375 -100.0%
Value US$137,500
Quart Barry D Non-Executive Director
Transaction date
Planned sale
Price
90.00
Quantity 1,000 -100.0%
Value US$90,000
Quart Barry D Non-Executive Director
Transaction date
Planned sale
Price
83.31
Quantity 1,000 -100.0%
Value US$83,310
Goldberg Mark Alan EVP, Medical & Reg. Strategy Officer
Transaction date
Planned sale
Price
80.00
Quantity 21,597 -97.9%
Value US$1,727,760
BOESS CARSTEN SVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
83.46
Quantity 200 -100.0%
Value US$16,692
BOESS CARSTEN SVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
82.71
Quantity 1,591 -88.8%
Value US$131,592
BOESS CARSTEN SVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
81.75
Quantity 8,136 -82.0%
Value US$665,118
Quinn Anthony EVP, CMO & Head of R&D Officer
Transaction date
Planned sale
Price
85.76
Quantity 1,050 -6.3%
Value US$90,048
Quinn Anthony EVP, CMO & Head of R&D Officer
Transaction date
Planned sale
Price
84.72
Quantity 4,746 -22.3%
Value US$402,081
Quinn Anthony EVP, CMO & Head of R&D Officer
Transaction date
Planned sale
Price
83.50
Quantity 3,529 -14.2%
Value US$294,672
Quinn Anthony EVP, CMO & Head of R&D Officer
Transaction date
Planned sale
Price
82.80
Quantity 10,675 -30.1%
Value US$883,890
Heberlig Chris Group Vice President, Finance Officer
Transaction date
Planned sale
Price
99.08
Quantity 3,037 -94.1%
Value US$300,906
Heberlig Chris Group Vice President, Finance Officer
Transaction date
Planned sale
Price
98.49
Quantity 3,933 -54.9%
Value US$387,361
Heberlig Chris Group Vice President, Finance Officer
Transaction date
Planned sale
Price
96.75
Quantity 700 -8.9%
Value US$67,725
BAKER FELIX Non-Executive Director Large shareholder
Transaction date
Purchase
Price
105.75
Quantity 9,031 +4.5%
Value US$955,028
BAKER JULIAN Non-Executive Director Large shareholder
Transaction date
Purchase
Price
105.75
Quantity 9,031 +4.5%
Value US$955,028
BAKER FELIX Non-Executive Director Large shareholder
Transaction date
Purchase
Price
105.75
Quantity 365,969 +4.7%
Value US$38,701,222
BAKER JULIAN Non-Executive Director Large shareholder
Transaction date
Purchase
Price
105.75
Quantity 365,969 +4.7%
Value US$38,701,222
BOESS CARSTEN SVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
104.22
Quantity 894 -100.0%
Value US$93,173
BOESS CARSTEN SVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
103.05
Quantity 1,745 -66.1%
Value US$179,822
BOESS CARSTEN SVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
102.18
Quantity 3,207 -54.9%
Value US$327,691
BOESS CARSTEN SVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
101.14
Quantity 3,081 -34.5%
Value US$311,612
BOESS CARSTEN SVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
100.07
Quantity 1,000 -10.1%
Value US$100,070
Patel Sanj K President & CEO Executive Director
Transaction date
Planned sale
Price
91.58
Quantity 400 -28.0%
Value US$36,632
Patel Sanj K President & CEO Executive Director
Transaction date
Planned sale
Price
90.85
Quantity 1,502 -51.2%
Value US$136,457
Patel Sanj K President & CEO Executive Director
Transaction date
Planned sale
Price
89.27
Quantity 5,600 -65.6%
Value US$499,912
Patel Sanj K President & CEO Executive Director
Transaction date
Planned sale
Price
88.31
Quantity 18,652 -68.6%
Value US$1,647,158
Patel Sanj K President & CEO Executive Director
Transaction date
Planned sale
Price
87.19
Quantity 24,817 -47.7%
Value US$2,163,794
Patel Sanj K President & CEO Executive Director
Transaction date
Planned sale
Price
90.10
Quantity 812 -44.1%
Value US$73,161
Patel Sanj K President & CEO Executive Director
Transaction date
Planned sale
Price
88.95
Quantity 8,402 -82.0%
Value US$747,358
Patel Sanj K President & CEO Executive Director
Transaction date
Planned sale
Price
88.38
Quantity 32,609 -76.1%
Value US$2,881,983
Patel Sanj K President & CEO Executive Director
Transaction date
Planned sale
Price
87.16
Quantity 9,506 -18.2%
Value US$828,543
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2015-06-09 2015-06-08 S Sale Williams Glen

SVP, Technical Operations

Officer
12,146 +37.1%
113.13
US$2,395,368 		12,146 +37.1% 113.13 US$2,395,368
2015-06-09 2015-06-08 S Sale Williams Glen

SVP, Technical Operations

Officer
9,205 -25.4%
374.73
US$434,583 		9,205 -25.4% 374.73 US$434,583
2015-05-08 2015-05-06 PlS Planned sale Williams Glen

SVP, Technical Operations

Officer
86,364 -32.2%
298.05
US$376,045 		86,364 -32.2% 298.05 US$376,045
2015-05-08 2015-05-06 PlS Planned sale Williams Glen

SVP, Technical Operations

Officer
100 -15.0%
206.97
US$20,697 		100 -15.0% 206.97 US$20,697
2015-05-08 2015-05-06 PlS Planned sale Williams Glen

SVP, Technical Operations

Officer
400 -37.5%
206.27
US$82,508 		400 -37.5% 206.27 US$82,508
2015-05-08 2015-05-06 PlS Planned sale Williams Glen

SVP, Technical Operations

Officer
400 -27.2%
204.94
US$81,976 		400 -27.2% 204.94 US$81,976
2015-05-08 2015-05-06 PlS Planned sale Williams Glen

SVP, Technical Operations

Officer
666 -31.2%
203.99
US$135,857 		666 -31.2% 203.99 US$135,857
2015-04-29 2015-04-27 PlS Planned sale Quinn Anthony

EVP, CMO & Head of R&D

Officer
10,000 -64.0%
110.00
US$1,100,000 		10,000 -64.0% 110.00 US$1,100,000
2015-04-17 2015-04-15 PlS Planned sale Quinn Anthony

EVP, CMO & Head of R&D

Officer
10,000 -39.0%
105.00
US$1,050,000 		10,000 -39.0% 105.00 US$1,050,000
2015-04-09 2015-04-08 PlS Planned sale Williams Glen

SVP, Technical Operations

Officer
39,863 -98.8%
96.08
US$3,830,037 		39,863 -98.8% 96.08 US$3,830,037
2015-04-09 2015-04-07 PlS Planned sale Williams Glen

SVP, Technical Operations

Officer
2,769 -85.5%
96.04
US$265,935 		2,769 -85.5% 96.04 US$265,935
2015-04-08 2015-04-06 PlS Planned sale Quinn Anthony

EVP, CMO & Head of R&D

Officer
29,503 -65.4%
93.76
US$2,766,201 		29,503 -65.4% 93.76 US$2,766,201
2015-03-13 2015-03-11 PlS Planned sale Heberlig Chris

SVP, Finance and Business Ops.

Officer
300 -43.5%
105.74
US$31,722 		300 -43.5% 105.74 US$31,722
2015-03-13 2015-03-11 PlS Planned sale Heberlig Chris

SVP, Finance and Business Ops.

Officer
1,510 -68.6%
104.57
US$157,901 		1,510 -68.6% 104.57 US$157,901
2015-03-13 2015-03-11 PlS Planned sale Heberlig Chris

SVP, Finance and Business Ops.

Officer
3,290 -59.9%
103.55
US$340,680 		3,290 -59.9% 103.55 US$340,680
2015-03-13 2015-03-11 PlS Planned sale Heberlig Chris

SVP, Finance and Business Ops.

Officer
900 -14.1%
102.46
US$92,214 		900 -14.1% 102.46 US$92,214
2015-03-13 2015-03-11 PlS Planned sale Heberlig Chris

SVP, Finance and Business Ops.

Officer
600 -8.6%
101.38
US$60,828 		600 -8.6% 101.38 US$60,828
2015-03-13 2015-03-11 PlS Planned sale Heberlig Chris

SVP, Finance and Business Ops.

Officer
900 -11.4%
100.44
US$90,396 		900 -11.4% 100.44 US$90,396
2015-02-19 2015-02-17 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
1,842 -100.0%
101.69
US$187,313 		1,842 -100.0% 101.69 US$187,313
2015-02-19 2015-02-17 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
16,716 -90.1%
100.74
US$1,683,970 		16,716 -90.1% 100.74 US$1,683,970
2015-02-19 2015-02-17 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
14,750 -44.3%
99.97
US$1,474,558 		14,750 -44.3% 99.97 US$1,474,558
2015-02-19 2015-02-17 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
8,989 -21.3%
98.85
US$888,563 		8,989 -21.3% 98.85 US$888,563
2015-01-09 2015-01-07 B Purchase BAKER JULIAN Non-Executive Director Large shareholder
1,000,000 +12.2%
94.19
US$94,190,000 		1,000,000 +12.2% 94.19 US$94,190,000
2015-01-09 2015-01-07 B Purchase BAKER FELIX Non-Executive Director Large shareholder
1,000,000 +12.2%
94.19
US$94,190,000 		1,000,000 +12.2% 94.19 US$94,190,000
2014-12-30 2014-12-29 PlS Planned sale Heberlig Chris

Group Vice President, Finance

Officer
300 -49.7%
93.04
US$27,912 		300 -49.7% 93.04 US$27,912
2014-12-30 2014-12-29 PlS Planned sale Heberlig Chris

Group Vice President, Finance

Officer
1,156 -65.7%
92.10
US$106,468 		1,156 -65.7% 92.10 US$106,468
2014-12-30 2014-12-29 PlS Planned sale Heberlig Chris

Group Vice President, Finance

Officer
2,844 -61.8%
91.34
US$259,771 		2,844 -61.8% 91.34 US$259,771
2014-12-30 2014-12-29 PlS Planned sale Heberlig Chris

Group Vice President, Finance

Officer
1,800 -28.1%
89.90
US$161,820 		1,800 -28.1% 89.90 US$161,820
2014-12-19 2014-12-17 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
26,960 -96.3%
90.06
US$2,428,018 		26,960 -96.3% 90.06 US$2,428,018
2014-12-19 2014-12-17 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
4,488 -13.8%
87.26
US$391,623 		4,488 -13.8% 87.26 US$391,623
2014-12-19 2014-12-17 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
13,536 -29.4%
87.55
US$1,185,077 		13,536 -29.4% 87.55 US$1,185,077
2014-12-19 2014-12-17 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
5,016 -9.8%
87.25
US$437,646 		5,016 -9.8% 87.25 US$437,646
2014-10-30 2014-10-30 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
22,904 -100.0%
80.11
US$1,834,839 		22,904 -100.0% 80.11 US$1,834,839
2014-10-30 2014-10-28 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
1,000 -100.0%
80.00
US$80,000 		1,000 -100.0% 80.00 US$80,000
2014-10-30 2014-10-28 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
1,500 -60.0%
80.00
US$120,000 		1,500 -60.0% 80.00 US$120,000
2014-09-19 2014-09-19 PlS Planned sale Goldberg Mark Alan

EVP, Medical & Reg. Strategy

Officer
790 -58.4%
65.24
US$51,540 		790 -58.4% 65.24 US$51,540
2014-09-18 2014-09-17 PlS Planned sale Goldberg Mark Alan

EVP, Medical & Reg. Strategy

Officer
4,200 -88.2%
65.06
US$273,252 		4,200 -88.2% 65.06 US$273,252
2014-09-18 2014-09-16 PlS Planned sale Goldberg Mark Alan

EVP, Medical & Reg. Strategy

Officer
9,379 -94.3%
65.01
US$609,729 		9,379 -94.3% 65.01 US$609,729
2014-09-04 2014-09-02 PlS Planned sale Quinn Anthony

EVP, CMO & Head of R&D

Officer
300 -1.2%
72.88
US$21,864 		300 -1.2% 72.88 US$21,864
2014-09-04 2014-09-02 PlS Planned sale Quinn Anthony

EVP, CMO & Head of R&D

Officer
700 -2.6%
71.96
US$50,372 		700 -2.6% 71.96 US$50,372
2014-09-04 2014-09-02 PlS Planned sale Quinn Anthony

EVP, CMO & Head of R&D

Officer
400 -1.5%
70.50
US$28,200 		400 -1.5% 70.50 US$28,200
2014-09-04 2014-09-02 PlS Planned sale Quinn Anthony

EVP, CMO & Head of R&D

Officer
8,600 -24.2%
69.88
US$600,968 		8,600 -24.2% 69.88 US$600,968
2014-06-26 2014-06-25 PlS Planned sale Williams Glen

SVP, Technical Operations

Officer
700 -72.5%
108.02
US$75,614 		700 -72.5% 108.02 US$75,614
2014-06-24 2014-06-20 PlS Planned sale Quart Barry D Non-Executive Director
1,375 -100.0%
100.00
US$137,500 		1,375 -100.0% 100.00 US$137,500
2014-06-19 2014-06-17 PlS Planned sale Quart Barry D Non-Executive Director
1,000 -100.0%
90.00
US$90,000 		1,000 -100.0% 90.00 US$90,000
2014-06-16 2014-06-12 PlS Planned sale Quart Barry D Non-Executive Director
1,000 -100.0%
83.31
US$83,310 		1,000 -100.0% 83.31 US$83,310
2014-06-12 2014-06-11 PlS Planned sale Goldberg Mark Alan

EVP, Medical & Reg. Strategy

Officer
21,597 -97.9%
80.00
US$1,727,760 		21,597 -97.9% 80.00 US$1,727,760
2014-05-20 2014-05-16 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
200 -100.0%
83.46
US$16,692 		200 -100.0% 83.46 US$16,692
2014-05-20 2014-05-16 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
1,591 -88.8%
82.71
US$131,592 		1,591 -88.8% 82.71 US$131,592
2014-05-20 2014-05-16 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
8,136 -82.0%
81.75
US$665,118 		8,136 -82.0% 81.75 US$665,118
2014-04-03 2014-04-01 PlS Planned sale Quinn Anthony

EVP, CMO & Head of R&D

Officer
1,050 -6.3%
85.76
US$90,048 		1,050 -6.3% 85.76 US$90,048
2014-04-03 2014-04-01 PlS Planned sale Quinn Anthony

EVP, CMO & Head of R&D

Officer
4,746 -22.3%
84.72
US$402,081 		4,746 -22.3% 84.72 US$402,081
2014-04-03 2014-04-01 PlS Planned sale Quinn Anthony

EVP, CMO & Head of R&D

Officer
3,529 -14.2%
83.50
US$294,672 		3,529 -14.2% 83.50 US$294,672
2014-04-03 2014-04-01 PlS Planned sale Quinn Anthony

EVP, CMO & Head of R&D

Officer
10,675 -30.1%
82.80
US$883,890 		10,675 -30.1% 82.80 US$883,890
2014-03-14 2014-03-12 PlS Planned sale Heberlig Chris

Group Vice President, Finance

Officer
3,037 -94.1%
99.08
US$300,906 		3,037 -94.1% 99.08 US$300,906
2014-03-14 2014-03-12 PlS Planned sale Heberlig Chris

Group Vice President, Finance

Officer
3,933 -54.9%
98.49
US$387,361 		3,933 -54.9% 98.49 US$387,361
2014-03-14 2014-03-12 PlS Planned sale Heberlig Chris

Group Vice President, Finance

Officer
700 -8.9%
96.75
US$67,725 		700 -8.9% 96.75 US$67,725
2014-03-07 2014-03-06 B Purchase BAKER FELIX Non-Executive Director Large shareholder
9,031 +4.5%
105.75
US$955,028 		9,031 +4.5% 105.75 US$955,028
2014-03-07 2014-03-06 B Purchase BAKER JULIAN Non-Executive Director Large shareholder
9,031 +4.5%
105.75
US$955,028 		9,031 +4.5% 105.75 US$955,028
2014-03-07 2014-03-06 B Purchase BAKER FELIX Non-Executive Director Large shareholder
365,969 +4.7%
105.75
US$38,701,222 		365,969 +4.7% 105.75 US$38,701,222
2014-03-07 2014-03-06 B Purchase BAKER JULIAN Non-Executive Director Large shareholder
365,969 +4.7%
105.75
US$38,701,222 		365,969 +4.7% 105.75 US$38,701,222
2014-02-20 2014-02-18 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
894 -100.0%
104.22
US$93,173 		894 -100.0% 104.22 US$93,173
2014-02-20 2014-02-18 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
1,745 -66.1%
103.05
US$179,822 		1,745 -66.1% 103.05 US$179,822
2014-02-20 2014-02-18 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
3,207 -54.9%
102.18
US$327,691 		3,207 -54.9% 102.18 US$327,691
2014-02-20 2014-02-18 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
3,081 -34.5%
101.14
US$311,612 		3,081 -34.5% 101.14 US$311,612
2014-02-20 2014-02-18 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
1,000 -10.1%
100.07
US$100,070 		1,000 -10.1% 100.07 US$100,070
2014-01-30 2014-01-29 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
400 -28.0%
91.58
US$36,632 		400 -28.0% 91.58 US$36,632
2014-01-30 2014-01-29 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
1,502 -51.2%
90.85
US$136,457 		1,502 -51.2% 90.85 US$136,457
2014-01-30 2014-01-29 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
5,600 -65.6%
89.27
US$499,912 		5,600 -65.6% 89.27 US$499,912
2014-01-30 2014-01-29 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
18,652 -68.6%
88.31
US$1,647,158 		18,652 -68.6% 88.31 US$1,647,158
2014-01-30 2014-01-29 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
24,817 -47.7%
87.19
US$2,163,794 		24,817 -47.7% 87.19 US$2,163,794
2014-01-30 2014-01-28 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
812 -44.1%
90.10
US$73,161 		812 -44.1% 90.10 US$73,161
2014-01-30 2014-01-28 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
8,402 -82.0%
88.95
US$747,358 		8,402 -82.0% 88.95 US$747,358
2014-01-30 2014-01-28 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
32,609 -76.1%
88.38
US$2,881,983 		32,609 -76.1% 88.38 US$2,881,983
2014-01-30 2014-01-28 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
9,506 -18.2%
87.16
US$828,543 		9,506 -18.2% 87.16 US$828,543
Explore more

More insider trading research around Alexion Pharma LLC

More insider trades in United States
Insider trading in North America